WeVote
Log In

Bill

Bill

AB 1332

Medicinal cannabis: shipments.

2025-2026 Regular Session Introduced by Patrick Ahrens

AB 1332 would allow direct shipment of medicinal cannabis from retailers to California consumers, but Governor vetoed the bill citing unspecified concerns about implementation.

Consideration of Governor's veto stricken from file.
#medicinalcannabis #shipments
0
WeVote Research Nonpartisan
Bill Summary · AB 1332

Legislative bill overview

AB 1332 would have authorized direct shipment of medicinal cannabis products from licensed retailers to California consumers, bypassing traditional in-store purchase requirements. The bill passed both chambers with bipartisan support but was vetoed by the Governor in October 2025.

Why is this important

This legislation addresses patient access and convenience for medicinal cannabis users, particularly those in remote areas or with mobility limitations. The veto suggests concerns about regulatory oversight, tax collection, or public health safeguards in a home-delivery model for controlled substances.

Potential points of contention

  • Regulatory enforcement: Difficulty verifying age, medical qualification, and preventing diversion to illegal markets through mail/courier delivery
  • Tax revenue and tracking: Challenges in monitoring sales tax compliance and excise tax collection on remote transactions
  • Federal-state conflict: Cannabis remains federally illegal, creating complications for interstate commerce and banking relationships
  • Public health concerns: Questions about product safety verification, dosing information, and preventing unauthorized use by minors or non-patients in households receiving shipments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.